Exciting advances in cancer treatment offer reasons for optimism in the field of bio-medicine. Innovative therapies like checkpoint inhibitors, Antibody Drug Conjugates (ADC), bi (and multi) specifics, CAR-T therapies, and cancer vaccines have shown promising results, sparking a revolution in the fight against cancer. The future of cancer therapeutics looks brighter than ever, and  Vantage is thrilled to be part of this transformative journey. Together with our collaborators, we are dedicated to pushing the boundaries of scientific understanding and making a tangible difference in patients’ lives.

Key Publications:

Key questions M&S can address

  • Incorporate human data to arrive at a mechanistic FIH dose.
  • Optimus: Predict Minimum Efficacious Dose
  • Simulate mono versus combo therapies

Case Studies

Scroll to Top